Colorectal Cancer
Showing NaN - NaN of 117
Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)
Recruiting
- Non-Small Cell Lung Cancer
- +4 more
- GRT-C903
- +3 more
-
Phoenix, Arizona
- +13 more
Jan 30, 2023
Colorectal Cancer Screening in Cystic Fibrosis
Recruiting
- Cystic Fibrosis
- +2 more
- Stool tests
-
Los Angeles, California
- +24 more
Jan 26, 2023
Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)
Recruiting
- Colorectal Cancer
- Metastatic Colorectal Cancer
- Onvansertib
- +2 more
-
Birmingham, Alabama
- +38 more
Jan 25, 2023
Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in France, United Kingdom, United States (NUC-3373 +
Recruiting
- Colorectal Cancer
- +4 more
- NUC-3373 + leucovorin
- +8 more
-
Boston, Massachusetts
- +9 more
Jan 23, 2023
Head and Neck Squamous Cell Carcinoma, Melanoma Excluding Uveal Melanoma, NSCLC, Squamous or Non-squamous Trial in Denver,
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +8 more
- XmAb®808
- Keytruda® (pembrolizumab)
-
Denver, Colorado
- +2 more
Jan 19, 2023
Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)
Recruiting
- Minimal Residual Disease
- +11 more
- ELI-002 2P
-
Duarte, California
- +10 more
Jan 18, 2023
Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily
Recruiting
- Solid Tumor
- +8 more
- TPST-1495 twice daily
- +2 more
-
Baltimore, Maryland
- +8 more
Jan 4, 2023
Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)
Active, not recruiting
- Melanoma
- +7 more
- Autogene cevumeran
- Atezolizumab
-
Scottsdale, Arizona
- +36 more
Dec 22, 2022
Tumors, Colorectal Cancer Trial in Grand Rapids, Nashville, Kirkland (MK-8353, Pembrolizumab)
Completed
- Neoplasms
- Colorectal Cancer
- MK-8353
- Pembrolizumab
-
Grand Rapids, Michigan
- +2 more
Dec 21, 2022
Validation for Early Cancer Detection and Minimal Residual
Recruiting
- Brain Cancer
- +19 more
-
Duarte, California
- +6 more
Nov 10, 2022
Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1
Active, not recruiting
- Hepatocellular Carcinoma
- +11 more
- Part 1 TPST-1120
- +3 more
-
San Francisco, California
- +10 more
Nov 1, 2022
Castration-resistant Prostate Cancer, NSCLC, Colorectal Cancer Trial in Australia, United States (SM08502, Abiraterone,
Active, not recruiting
- Castration-resistant Prostate Cancer
- +2 more
- SM08502
- +5 more
-
Tucson, Arizona
- +19 more
Oct 18, 2022
Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal
Recruiting
- Breast Cancer
- +15 more
- ATRC-101
- +2 more
-
Phoenix, Arizona
- +10 more
Sep 28, 2022
Colorectal Cancer Trial in Worldwide (Pembrolizumab, Pembrolizumab/Quavonlimab, Pembrolizumab/Favezelimab)
Recruiting
- Colorectal Cancer
- Pembrolizumab
- +4 more
-
Orange City, Florida
- +54 more
Aug 17, 2022
Colorectal Cancer, Triple Negative Breast Cancer, Gastric Cancer Trial in United States (navicixizumab+paclitaxel,
Recruiting
- Colorectal Cancer
- +3 more
- navicixizumab+paclitaxel
- +2 more
-
Hot Springs, Arkansas
- +5 more
Aug 9, 2022
Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan
Not yet recruiting
- Endometrial Cancer
- +4 more
- Datopotamab deruxtecan (Dato-DXd)
- +8 more
-
Los Angeles, California
- +52 more
Aug 3, 2022
NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +
Active, not recruiting
- Non-Small Cell Lung Cancer
- +12 more
- CPI-006
- +2 more
-
Tucson, Arizona
- +26 more
Aug 1, 2022
Mesothelioma, Mesotheliomas Pleural, Mesothelioma, Malignant Trial in Bethesda, Nashville (TC-510, Fludarabine,
Recruiting
- Mesothelioma
- +14 more
- TC-510
- +2 more
-
Nashville, TennesseeSarah Cannon Research Institute
Jul 14, 2022
Tissue and Biological Fluid Samples From Patients and Healthy
Recruiting
- Colorectal Cancer
- +4 more
- protein analysis
- +10 more
-
Nashville, Tennessee
- +3 more
Jul 7, 2022
Inherited Cancer Syndrome, Prostate Cancer, Colorectal Cancer Trial in Nashville (Correlative Studies (Survey), Correlative
Not yet recruiting
- Inherited Cancer Syndrome
- +4 more
- Correlative Studies (Survey)
- +4 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jul 5, 2022